Fast-track access to urologic care for patients with macroscopic haematuria is efficient and cost-effective : results from a prospective intervention study
(2016) In British Journal of Cancer 115. p.770-775- Abstract
Background:The delay between onset of macroscopic haematuria and diagnosis of bladder cancer is often long.Methods:We evaluated timely diagnosis and health-care costs for patients with macroscopic haematuria given fast-track access to diagnostics. During a 15-month period, a telephone hotline for fast-track diagnostics was provided in nine Swedish municipalities for patients aged ⩾50 years with macroscopic haematuria. The control group comprised 101 patients diagnosed with bladder cancer in the same catchment area with macroscopic haematuria who underwent regular diagnostic process.Results:In all 275 patients who called ‘the Red Phone’ hotline were investigated, and 47 of them (17%) were diagnosed with cancer and 36 of those had bladder... (More)
Background:The delay between onset of macroscopic haematuria and diagnosis of bladder cancer is often long.Methods:We evaluated timely diagnosis and health-care costs for patients with macroscopic haematuria given fast-track access to diagnostics. During a 15-month period, a telephone hotline for fast-track diagnostics was provided in nine Swedish municipalities for patients aged ⩾50 years with macroscopic haematuria. The control group comprised 101 patients diagnosed with bladder cancer in the same catchment area with macroscopic haematuria who underwent regular diagnostic process.Results:In all 275 patients who called ‘the Red Phone’ hotline were investigated, and 47 of them (17%) were diagnosed with cancer and 36 of those had bladder cancer. Median time from patient-reported haematuria to diagnosis was 29 (interquartile range (IQR) 14−104) days and 50 (IQR 27−165) days in the intervention and the control group, respectively (P=0.03). The median health-care costs were lower in the intervention group (655 (IQR 655−655) EUR) than in the control group (767 (IQR 490−1096) EUR) (P=0.002).Conclusions:Direct access to urologic expertise and fast-track diagnostics is motivated for patients with macroscopic haematuria to reduce diagnostic intervals and lower health-care expenditures.British Journal of Cancer advance online publication, 25 August 2016; doi:10.1038/bjc.2016.265 www.bjcancer.com.
(Less)
- author
- organization
- publishing date
- 2016-08-25
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- urologic care, macroscopic haematuria
- in
- British Journal of Cancer
- volume
- 115
- pages
- 6 pages
- publisher
- Nature Publishing Group
- external identifiers
-
- scopus:84983421935
- pmid:27560554
- wos:000384576100002
- ISSN
- 0007-0920
- DOI
- 10.1038/bjc.2016.265
- project
- Precision Medicine in Hereditary Cancer and Sarcoma; targeted surveillance, immunotherapy and individualized follow-up
- Precision Medicine in Hereditary Cancer and Sarcoma; targeted surveillance, immunotherapy and individualized follow-up
- language
- English
- LU publication?
- yes
- id
- de192e7d-2b01-4d70-9f55-a89f61cb7b1b
- date added to LUP
- 2016-09-21 12:31:08
- date last changed
- 2025-01-12 11:43:30
@article{de192e7d-2b01-4d70-9f55-a89f61cb7b1b, abstract = {{<p>Background:The delay between onset of macroscopic haematuria and diagnosis of bladder cancer is often long.Methods:We evaluated timely diagnosis and health-care costs for patients with macroscopic haematuria given fast-track access to diagnostics. During a 15-month period, a telephone hotline for fast-track diagnostics was provided in nine Swedish municipalities for patients aged ⩾50 years with macroscopic haematuria. The control group comprised 101 patients diagnosed with bladder cancer in the same catchment area with macroscopic haematuria who underwent regular diagnostic process.Results:In all 275 patients who called ‘the Red Phone’ hotline were investigated, and 47 of them (17%) were diagnosed with cancer and 36 of those had bladder cancer. Median time from patient-reported haematuria to diagnosis was 29 (interquartile range (IQR) 14−104) days and 50 (IQR 27−165) days in the intervention and the control group, respectively (P=0.03). The median health-care costs were lower in the intervention group (655 (IQR 655−655) EUR) than in the control group (767 (IQR 490−1096) EUR) (P=0.002).Conclusions:Direct access to urologic expertise and fast-track diagnostics is motivated for patients with macroscopic haematuria to reduce diagnostic intervals and lower health-care expenditures.British Journal of Cancer advance online publication, 25 August 2016; doi:10.1038/bjc.2016.265 www.bjcancer.com.</p>}}, author = {{Liedberg, Fredrik and Gerdtham, Ulf and Gralén, Katarina and Gudjonsson, Sigurdur and Jahnson, Staffan and Johansson, Irene and Hagberg, Oskar and Larsson, Staffan and Lind, Anna Karin and Löfgren, Annika and Wanegård, Jenny and Åberg, Hanna and Nilbert, Mef}}, issn = {{0007-0920}}, keywords = {{urologic care; macroscopic haematuria}}, language = {{eng}}, month = {{08}}, pages = {{770--775}}, publisher = {{Nature Publishing Group}}, series = {{British Journal of Cancer}}, title = {{Fast-track access to urologic care for patients with macroscopic haematuria is efficient and cost-effective : results from a prospective intervention study}}, url = {{http://dx.doi.org/10.1038/bjc.2016.265}}, doi = {{10.1038/bjc.2016.265}}, volume = {{115}}, year = {{2016}}, }